What is Petvivo Holdings's earnings per share (EPS)?

Petvivo Holdings (PETVW) reported diluted earnings per share of -$0.38 for fiscal year 2026. This represents a 7.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Petvivo Holdings (PETVW) Financials

PETVW

FY2026 annual

Revenue $1.1M +0.8% YoY

Net Income -$10.5M -24.7% YoY

EPS (Diluted) -$0.38 +7.3% YoY

Free Cash Flow -$6.1M -13.5% YoY

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Mar 31, 2026 Reported Jun 29, 2026 Currency USD FYE March

Newest figures come from the 10-K for FY2026, filed Jun 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PETVW SEC filings page.

Petvivo Holdings (PETVW) reported $1.1M in revenue for fiscal year 2026, up 0.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PETVW FY2026 2026-08-26

Development-stage spending remains the dominant mechanic: revenue is nearly flat while operating losses require recurring external financing.

Cash conversion is poor but transparent: FY2026 operating cash flow of -$6.1M was closer to the net loss of -$10.5M than to cash neutrality, while financing supplied $6.1M. The combination indicates that reported losses are accompanied by substantial cash needs, and those needs were largely offset by financing rather than operating receipts.

Revenue scale has stalled: FY2026 revenue was $1.1M, little changed from FY2025, yet gross margin fell from 87.8% to 66.1%. With volume essentially flat, the margin movement points to changing cost or revenue mix rather than fixed-cost absorption from growth.

R&D intensity remains structurally high: FY2026 research and development spending was $1.4M, exceeding revenue of $1.1M. SG&A was also $4.3M, so operating expenses—not the direct cost of revenue alone—remain the main constraint on reaching operating profitability.

Financial Health Signals

Financial health score not available

Petvivo Holdings does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/8

Petvivo Holdings passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Petvivo Holdings reported a net loss of $10.5M while operations used $6.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Petvivo Holdings reported an operating loss of $9.1M against $13K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$255K

YoY+13.3%

QoQ-11.0%

5Y CAGR+117.2%

Petvivo Holdings generated $255K in revenue in Q4 2026. This represents an increase of 13.3% from the same quarter a year earlier. Against the prior quarter it is down 11.0%.

EBITDA

-$2.6M

YoY-29.8%

QoQ-19.5%

Petvivo Holdings's EBITDA was -$2.6M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 29.8% from the same quarter a year earlier. Against the prior quarter it is down 19.5%.

Net Income

-$3.0M

YoY-22.5%

QoQ-35.2%

Petvivo Holdings reported -$3.0M in net income in Q4 2026. This represents a decrease of 22.5% from the same quarter a year earlier. Against the prior quarter it is down 35.2%.

EPS (Diluted)

Not reported for Q4 2026.

Cash & Balance Sheet

Free Cash Flow

-$812K

YoY+35.1%

QoQ+44.8%

Petvivo Holdings recorded an outflow of $812K in free cash flow in Q4 2026, representing a cash shortfall after capex. This represents an increase of 35.1% from the same quarter a year earlier. Against the prior quarter it is up 44.8%.

Cash & Debt

$201K

YoY-11.8%

QoQ+1005.4%

5Y CAGR+53.5%

10Y CAGR+94.6%

Petvivo Holdings held $201K in cash as of Q4 2026; long-term debt is not reported for that period.

Shares Outstanding

35M

YoY+44.8%

QoQ+1.6%

5Y CAGR+38.8%

10Y CAGR+16.0%

Petvivo Holdings had 35M shares outstanding in Q4 2026. This represents an increase of 44.8% from the same quarter a year earlier. Against the prior quarter it is up 1.6%.

Dividends Per Share

Not reported for Q4 2026.

Margins & Returns

Gross Margin

79.8%

YoY-1.5pp

QoQ+29.2pp

5Y CAGR+175.9pp

Petvivo Holdings's gross margin was 79.8% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is down 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 29.2 percentage points.

Return on Equity

-134.7%

YoY-77.4pp

QoQ-69.9pp

Petvivo Holdings's ROE was -134.7% in Q4 2026, measuring profit generated per dollar of shareholder equity. This is down 77.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 69.9 percentage points.

Operating Margin

Not shown for Q4 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q4 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending

$490K

YoY+36.7%

QoQ+51.7%

Petvivo Holdings invested $490K in research and development in Q4 2026. This represents an increase of 36.7% from the same quarter a year earlier. Against the prior quarter it is up 51.7%.

Capital Expenditures

YoY-100.0%

QoQ-100.0%

Petvivo Holdings reported no capital expenditure in Q4 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Share Buybacks

Not reported for Q4 2026.

PETVW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PETVW quarterly income statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.1M+0.8%	$1.1M+16.9%	$969K+5.6%	$917K+693.5%	$116K+819.0%	$13K+250.6%	$4K	N/A	$2K-78.8%	$7K-90.5%	$75K	N/A	N/A	$0	$0
Cost of Revenue	$387K+181.0%	$138K+35.2%	$102K-53.9%	$221K+9.9%	$201K+1780.8%	$11K-45.7%	$20K-74.7%	$78K	N/A	N/A	N/A	N/A	N/A	$0	$0
Gross Profit	$755K-24.1%	$995K+14.8%	$867K+24.5%	$696K+913.5%	-$86K-4644.2%	$2K+111.7%	-$16K+79.3%	-$78K-5261.3%	$2K-78.8%	$7K-90.5%	$75K	N/A	N/A	$0	$0
R&D Expenses	$1.4M-10.6%	$1.6M+13.5%	$1.4M+40.0%	$996K+109.8%	$475K+383.4%	$98K+675.2%	$13K-93.7%	$201K+69.0%	$119K-29.2%	$168K-0.4%	$169K+3735.3%	$4K	N/A	$0	N/A
SG&A Expenses	$4.3M-10.2%	$4.8M-27.9%	$6.7M+33.3%	$5.0M+59.5%	$3.1M+78.1%	$1.8M-2.7%	$1.8M	N/A	$2.2M	N/A	$3.2M+163.7%	$1.2M	-$30K	N/A	N/A
Operating Income	-$9.1M-12.5%	-$8.1M+24.2%	-$10.6M-21.6%	-$8.7M-72.7%	-$5.1M-158.1%	-$2.0M+2.8%	-$2.0M	N/A	-$2.3M	N/A	-$3.3M-170.5%	-$1.2M	N/A	N/A	N/A
EBITDA	-$8.6M-8.5%	-$7.9M+24.9%	-$10.5M-21.8%	-$8.6M-72.7%	-$5.0M-166.6%	-$1.9M-28.5%	-$1.5M	N/A	-$1.6M	N/A	-$2.5M	N/A	N/A	N/A	N/A
Interest Expense	$13K+106.4%	$6K+195.0%	-$6K-140.8%	$16K+60.8%	$10K-95.7%	$229K+610.3%	$32K-62.1%	$85K+14.8%	$74K-60.7%	$189K-30.3%	$271K-32.2%	$399K	N/A	N/A	N/A
Net Income	-$10.5M-24.7%	-$8.4M+23.3%	-$11.0M-25.7%	-$8.7M-73.8%	-$5.0M-42.4%	-$3.5M-69.1%	-$2.1M	N/A	-$2.3M	N/A	-$4.7M-202.2%	-$1.6M	-$86K	N/A	N/A
EPS (Basic)	-$0.38+7.3%	-$0.41+47.4%	-$0.78+8.2%	-$0.85-49.1%	-$0.570.0%	-$0.57	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0.00	$0.00
EPS (Diluted)	-$0.38+7.3%	-$0.41+47.4%	-$0.78+8.2%	-$0.85	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	30M+47.2%	20M+46.7%	14M+36.7%	10M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Revenue	$255K+13.3%	$286K-51.0%	$303K+51.1%	$298K+140.4%	$225K+365.6%	$583K-2.1%	$201K-3.2%	$124K+5.6%
Cost of Revenue	$51K+22.5%	$141K+129.9%	$83K+293.3%	$111K+752.5%	$42K+725.9%	$61K-1.7%	$21K-3.2%	$13K+5.6%
Gross Profit	$203K+11.2%	$145K-72.3%	$220K+22.6%	$187K+68.6%	$183K+323.2%	$522K-2.2%	$180K-3.2%	$111K+5.6%
R&D Expenses	$490K+36.7%	$323K-13.2%	$261K-43.8%	$341K-12.1%	$359K-8.2%	$372K+5.8%	$465K+29.5%	$388K+31.9%
SG&A Expenses	$776K-31.8%	$1.3M+5.7%	$1.2M-2.4%	$1.1M-13.3%	$1.1M-41.8%	$1.2M-7.6%	$1.3M-25.1%	$1.2M-30.0%
Operating Income	-$3.0M-42.4%	-$2.2M-24.6%	-$2.1M+5.0%	-$1.8M+9.8%	-$2.1M+21.5%	-$1.8M+17.6%	-$2.2M+26.2%	-$2.0M+29.3%
EBITDA	-$2.6M-29.8%	-$2.2M-26.1%	-$2.0M+4.4%	-$1.7M+14.1%	-$2.0M+23.4%	-$1.7M+17.9%	-$2.1M+26.5%	-$2.0M+29.7%
Interest Expense	-$1.1M-177432.7%	$0-100.0%	$942K+38320.0%	$122K+4529.7%	$593	$461+122.0%	$2K+200.4%	$3K
Net Income	-$3.0M-22.5%	-$2.2M-24.7%	-$3.0M-38.3%	-$2.3M-12.9%	-$2.4M+8.7%	-$1.8M-0.4%	-$2.2M+40.6%	-$2.0M+29.3%
EPS (Basic)	N/A	-$0.07+22.2%	-$0.110.0%	-$0.09+18.2%	N/A	-$0.09+25.0%	-$0.11+60.7%	-$0.11+56.0%
EPS (Diluted)	N/A	-$0.07	-$0.110.0%	-$0.09+18.2%	N/A	-$0.09+25.0%	-$0.11	-$0.11
Diluted Shares (Avg)	N/A	34M	28M+37.2%	24M+30.1%	N/A	21M+44.6%	20M	19M

Not reported in any period shown, so not listed: Income Tax.

PETVW Balance Sheet

PETVW quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$3.6M-61.7%	$9.3M+199.8%	$3.1M+27.7%	$2.4M-67.2%	$7.4M+789.2%	$835K+59.9%	$523K-24.4%	$691K-55.9%	$1.6M-17.4%	$1.9M-88.6%	$16.7M+2087.7%	$763K	$72K+5221.9%	$1K-63.8%	$4K
Current Assets	$1.9M-66.8%	$5.6M+438.5%	$1.0M-26.8%	$1.4M-78.9%	$6.8M+4490.7%	$147K-25.3%	$197K+253.3%	$56K-81.1%	$296K+764.9%	$34K-3.1%	$35K-87.2%	$275K	$2K+44.4%	$1K-63.8%	$4K
Cash & Equivalents	$201K-11.8%	$228K+160.5%	$87K-81.6%	$475K-92.2%	$6.1M+25800.5%	$24K+122.8%	$11K+63.8%	$6K-97.3%	$237K+833.1%	$25K+9758.1%	$258-99.4%	$40K	$721+220.4%	$225-78.9%	$1K
Short-Term Investments	$150K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory	$538K+66.4%	$324K-17.1%	$390K+5.3%	$370K+276.6%	$98K+165.9%	$37K-26.6%	$50K+303.0%	$12K-51.1%	$26K	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$101K+66.5%	$61K+224.5%	$19K-78.5%	$87K+3239.3%	$3K	N/A	$1K	N/A	$1630.0%	$163	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$150K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$13.4M	N/A	N/A	N/A	N/A
Total Liabilities	$1.4M-73.1%	$5.1M+110.8%	$2.4M+41.7%	$1.7M+19.0%	$1.4M-16.8%	$1.7M+11.1%	$1.6M+1.5%	$1.5M+7.3%	$1.4M+32.9%	$1.1M-93.6%	$16.8M+2685.8%	$602K	$256K+43.3%	$179K+127.3%	$79K
Current Liabilities	$1.4M-68.1%	$4.3M+205.6%	$1.4M-2.8%	$1.5M+23.9%	$1.2M-16.5%	$1.4M+22.4%	$1.1M-25.3%	$1.5M+7.3%	$1.4M+32.9%	$1.1M-27.2%	$1.5M+145.8%	$602K	$256K+43.3%	$179K+127.3%	$79K
Non-Current Liabilities	$0-100.0%	$803K-21.0%	$1.0M+290.8%	$260K-2.6%	$267K-18.4%	$327K-20.4%	$411K	$0	$0	$0-100.0%	$15.3M	$0	$0	$0	$0
Total Equity	$2.2M-47.9%	$4.2M+515.1%	$686K-5.4%	$725K-87.9%	$6.0M+767.4%	-$897K+13.4%	-$1.0M-22.7%	-$845K-718.2%	$137K-83.3%	$820K+1265.6%	-$70K-143.6%	$161K	-$185K-3.9%	-$178K-136.9%	-$75K
Retained Earnings	-$102.1M-11.9%	-$91.2M-10.1%	-$82.8M-15.2%	-$71.8M-13.8%	-$63.1M-8.6%	-$58.1M-6.5%	-$54.6M-4.0%	-$52.5M-10.0%	-$47.7M-5.1%	-$45.4M-52.0%	-$29.9M-13.9%	-$26.2M	$121K+133.1%	-$366K-39.0%	-$263K

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Total Assets	$3.6M-61.7%	$4.4M+40.6%	$5.3M+65.0%	$6.9M+138.5%	$9.3M+199.8%	$3.1M-14.3%	$3.2M-21.5%	$2.9M-6.8%
Current Assets	$1.9M-66.8%	$1.4M+12.8%	$2.1M+69.3%	$4.4M+400.1%	$5.6M+438.5%	$1.2M-17.8%	$1.2M-38.2%	$880K-13.4%
Cash & Equivalents	$201K-11.8%	$18K-37.1%	$768K+508.3%	$3.3M+26513.9%	$228K+160.5%	$29K-63.9%	$126K+128.5%	$12K-94.3%
Inventory	$538K+66.4%	$605K+71.3%	$578K+55.4%	$529K+38.0%	$324K-17.1%	$353K-24.4%	$372K-14.3%	$384K-5.5%
Accounts Receivable	$101K+66.5%	$30K-93.9%	$138K+3.2%	$26K-64.0%	$61K+224.5%	$493K-4.9%	$134K-14.2%	$72K+52.9%
Total Liabilities	$1.4M-73.1%	$997K-73.8%	$1.1M-61.3%	$3.2M+53.4%	$5.1M+110.8%	$3.8M+39.2%	$2.8M-9.6%	$2.1M-23.8%
Current Liabilities	$1.4M-68.1%	$988K-66.3%	$1.1M-43.3%	$3.1M+185.7%	$4.3M+205.6%	$2.9M+76.7%	$1.9M-3.0%	$1.1M-25.5%
Non-Current Liabilities	$0-100.0%	$9K-99.0%	$23K-97.5%	$42K-95.7%	$803K-21.0%	$871K-18.8%	$920K-20.6%	$968K-21.7%
Total Equity	$2.2M-47.9%	$3.4M+586.3%	$4.2M+922.3%	$3.7M+349.8%	$4.2M+515.1%	-$695K-177.6%	$409K-58.6%	$830K+108.3%
Retained Earnings	-$102.1M-11.9%	-$99.0M-11.5%	-$96.7M-11.1%	-$93.5M-10.2%	-$91.2M-10.1%	-$88.8M-10.8%	-$87.0M-11.0%	-$84.8M-13.5%

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill, Long-Term Debt.

PETVW Cash Flow Statement

PETVW quarterly cash flow statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$6.1M-14.8%	-$5.3M+28.3%	-$7.4M-9.2%	-$6.8M-62.7%	-$4.2M-444.2%	-$767K-54.0%	-$498K+32.4%	-$736K-28.0%	-$575K-302.2%	-$143K+79.3%	-$690K-73.2%	-$398K	-$71K	N/A	N/A
Depreciation & Amortization	$511K+192.9%	$175K+37.6%	$127K+10.8%	$114K+75.6%	$65K-24.9%	$87K-84.5%	$560K-13.5%	$647K+0.5%	$643K-13.9%	$747K+0.4%	$744K	N/A	N/A	N/A	N/A
Stock-Based Compensation	$1.9M+69.7%	$1.1M-47.5%	$2.1M+44.2%	$1.5M+108.1%	$703K+55.3%	$453K-47.5%	$863K-47.5%	$1.6M+90.5%	$863K+118.2%	$395K	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	$8K-87.8%	$63K-79.5%	$309K-27.1%	$424K+175.2%	$154K+9.5%	$141K+329.0%	$33K+20.9%	$27K+41.4%	$19K-47.4%	$36K	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	-$6.1M-13.5%	-$5.4M+30.3%	-$7.7M-7.1%	-$7.2M-66.7%	-$4.3M-376.8%	-$908K-71.0%	-$531K+30.5%	-$764K-28.5%	-$594K-231.2%	-$179K	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$12K+102.1%	-$563K-82.3%	-$309K+27.1%	-$424K-131.4%	-$183K-14.4%	-$160K-151.5%	-$64K+38.6%	-$104K-65.0%	-$63K-72.5%	-$36K	N/A	-$388K	N/A	N/A	N/A
Financing Cash Flow	$6.1M+0.7%	$6.0M-17.9%	$7.3M+362.6%	$1.6M-84.8%	$10.4M+1010.4%	$940K+66.2%	$566K-7.1%	$609K-28.3%	$850K+315.4%	$205K-68.5%	$651K-17.3%	$787K	$72K	N/A	N/A

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Operating Cash Flow	-$812K+34.0%	-$1.5M-52.6%	-$2.2M-37.1%	-$1.6M-6.7%	-$1.2M+19.3%	-$961K+25.5%	-$1.6M+34.5%	-$1.5M+29.3%
Depreciation & Amortization	$360K+374.3%	$15K-54.1%	$19K-43.9%	$118K+251.9%	$76K+129.1%	$32K+5.8%	$33K+2.6%	$33K+7.5%
Stock-Based Compensation	N/A	N/A	N/A	$133K-62.2%	N/A	N/A	N/A	$352K-14.7%
Capital Expenditures	$0-100.0%	-$5K-78.0%	N/A	N/A	$21K-27.6%	$24K-87.3%	$3K-92.6%	$15K-68.0%
Free Cash Flow	-$812K+35.1%	-$1.5M-49.5%	N/A	N/A	-$1.3M+19.5%	-$985K+33.3%	-$1.6M+35.5%	-$1.5M+30.1%
Investing Cash Flow	$0+100.0%	$5K+122.0%	N/A	N/A	-$521K-1678.7%	-$24K+87.3%	-$3K+92.6%	-$15K+68.0%
Financing Cash Flow	$995K-49.0%	$712K-19.8%	-$348K-120.3%	$4.7M+220.3%	$1.9M+24.9%	$888K-40.9%	$1.7M-26.1%	$1.5M-24.8%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

PETVW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PETVW quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	66.1%-21.7pp	87.8%-1.7pp	89.5%+13.6pp	75.9%+149.9pp	-74.0%-89.0pp	15.0%	-449.3%	N/A	100.0%0.0pp	100.0%0.0pp	100.0%	N/A	N/A	N/A	N/A
Operating Margin	-793.9%	-711.3%	-1096.4%	-952.2%	-4374.7%	-15574.7%	-56191.0%	N/A	-151345.5%	N/A	-4334.9%	N/A	N/A	N/A	N/A
Net Margin	-917.5%	-741.6%	-1130.9%	-950.5%	-4338.8%	-28007.5%	-58047.2%	N/A	-154790.6%	N/A	-6307.7%	N/A	N/A	N/A	N/A
Return on Equity	-476.2%-277.1pp	-199.1%+1398.0pp	-1597.1%-394.7pp	-1202.4%-1118.6pp	-83.8%	N/A	N/A	N/A	-1710.5%	N/A	N/A	-970.9%	N/A	N/A	N/A
Return on Assets	-292.8%-202.9pp	-89.9%+261.7pp	-351.7%+5.8pp	-357.4%-289.9pp	-67.5%+354.2pp	-421.8%-23.2pp	-398.6%	N/A	-149.1%	N/A	-28.3%+176.9pp	-205.2%	-119.8%	N/A	N/A
Current Ratio	1.35+0.1x	1.30+0.6x	0.74-0.2x	0.98-4.8x	5.76+5.7x	0.10-0.1x	0.17+0.1x	0.04-0.2x	0.21+0.2x	0.030.0x	0.02-0.4x	0.46	0.010.0x	0.010.0x	0.05
Debt-to-Equity	0.63-0.6x	1.21-2.3x	3.54+1.2x	2.36+2.1x	0.24	N/A	N/A	N/A	10.47+9.2x	1.31	N/A	3.73	N/A	N/A	N/A
Asset Turnover	0.32+0.2x	0.12-0.2x	0.31-0.1x	0.38+0.4x	0.020.0x	0.020.0x	0.01	N/A	0.000.0x	0.000.0x	0.00	N/A	N/A	0.000.0x	0.00
FCF Margin	-535.6%	-475.5%	-797.8%	-787.0%	-3745.3%	-7217.8%	-14796.0%	N/A	-39366.0%	-2519.4%	N/A	N/A	N/A	N/A	N/A

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Gross Margin	79.8%-1.5pp	50.6%-38.9pp	72.6%-16.9pp	62.8%-26.7pp	81.3%-8.2pp	89.5%0.0pp	89.5%0.0pp	89.5%0.0pp
Operating Margin	-1162.8%	-766.0%	-681.0%	-619.9%	-925.4%	-301.4%	-1082.6%	-1652.0%
Net Margin	-1163.4%	-766.0%	-991.8%	-776.8%	-1076.6%	-301.2%	-1083.8%	-1654.2%
Return on Equity	-134.7%-77.4pp	-64.9%	-71.9%+459.8pp	-61.9%+184.8pp	-57.3%+329.1pp	N/A	-531.7%-161.4pp	-246.8%+479.8pp
Return on Assets	-82.8%-56.9pp	-50.1%+6.4pp	-57.2%+11.1pp	-33.5%+37.3pp	-25.9%+59.2pp	-56.5%-8.2pp	-68.3%+21.9pp	-70.9%+22.5pp
Current Ratio	1.35+0.1x	1.40+1.0x	2.00+1.3x	1.41+0.6x	1.30+0.6x	0.42-0.5x	0.67-0.4x	0.81+0.1x
Debt-to-Equity	0.63-0.6x	0.30	0.26-6.5x	0.85-1.6x	1.21-2.3x	N/A	6.79+3.7x	2.48-4.3x
Asset Turnover	0.070.0x	0.07-0.1x	0.060.0x	0.040.0x	0.020.0x	0.190.0x	0.060.0x	0.040.0x
FCF Margin	-318.9%	-514.4%	N/A	N/A	-556.7%	-168.8%	-799.0%	-1249.0%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Petvivo Holdings PETVW	FY2026	$1.1M	-$10.5M	N/A	N/A	—
Petvivo Hldgs Inc PETV	FY2026	$1.1M	-$10.5M	N/A	$24.7M	—
Ir-Med Inc IRME	FY2024	N/A	N/A	N/A	$231K	—
QHSLab Inc USAQ	FY2025	$2.7M	-$457K	-17.0%	$4.8M	—
Vivos RDGL	FY2025	$68K	-$3.1M	N/A	$24.5M	—
CS Diagnostics CSDX	FY2024	N/A	$761	N/A	$7.2M	—

Where Petvivo Holdings Ranks

Frequently Asked Questions

What is Petvivo Holdings's annual revenue?

Petvivo Holdings (PETVW) reported $1.1M in total revenue for fiscal year 2026. This represents a 0.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Petvivo Holdings's revenue growing?

Petvivo Holdings (PETVW) revenue grew by 0.8% year-over-year, from $1.1M to $1.1M in fiscal year 2026.

Is Petvivo Holdings profitable?

No, Petvivo Holdings (PETVW) reported a net income of -$10.5M in fiscal year 2026.

What is Petvivo Holdings's EBITDA?

Petvivo Holdings (PETVW) had EBITDA of -$8.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is Petvivo Holdings's gross margin?

Petvivo Holdings (PETVW) had a gross margin of 66.1% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Petvivo Holdings's return on equity (ROE)?

Petvivo Holdings (PETVW) has a return on equity of -476.2% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Petvivo Holdings's free cash flow?

Petvivo Holdings (PETVW) recorded an outflow of $6.1M in free cash flow during fiscal year 2026. This represents a -13.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Petvivo Holdings's operating cash flow?

Petvivo Holdings (PETVW) recorded an outflow of $6.1M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

What are Petvivo Holdings's total assets?

Petvivo Holdings (PETVW) had $3.6M in total assets as of fiscal year 2026, including both current and long-term assets.

What are Petvivo Holdings's capital expenditures?

Petvivo Holdings (PETVW) invested $8K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Petvivo Holdings spend on research and development?

Petvivo Holdings (PETVW) invested $1.4M in research and development during fiscal year 2026.

How many shares does Petvivo Holdings have outstanding?

Petvivo Holdings (PETVW) had 35M shares outstanding as of fiscal year 2026.

What is Petvivo Holdings's current ratio?

Petvivo Holdings (PETVW) had a current ratio of 1.35 as of fiscal year 2026, which is considered adequate.

What is Petvivo Holdings's debt-to-equity ratio?

Petvivo Holdings (PETVW) had a debt-to-equity ratio of 0.63 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Petvivo Holdings's return on assets (ROA)?

Petvivo Holdings (PETVW) had a return on assets of -292.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

How does Petvivo Holdings's liquidity compare with its operating cash outflow?

At the end of fiscal year 2026, Petvivo Holdings (PETVW) held $501K in cash, cash equivalents and investments, and reported an operating cash outflow of $6.1M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Petvivo Holdings's Piotroski F-Score?

Petvivo Holdings (PETVW) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Petvivo Holdings's earnings high quality?

Petvivo Holdings (PETVW) reported a net loss of $10.5M while operations used $6.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Petvivo Holdings cover its interest payments?

Petvivo Holdings (PETVW) reported an operating loss of $9.1M against $13K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.